Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

Immunobiology - Tập 215 Số 8 - Trang 598-605 - 2010
Sadiye Amcaoglu Rieder1, Ashok Chauhan1, Ugra Singh1, Prakash Nagarkatti1
1Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC 29208, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Blazquez, 2006, Cannabinoid receptors as novel targets for the treatment of melanoma, Faseb J., 20, 2633, 10.1096/fj.06-6638fje

Di Filippo, 2004, Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN, J. Leukoc. Biol., 75, 453, 10.1189/jlb.0703303

Cabral, 1989, Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators, J. Toxicol. Environ. Health, 26, 175, 10.1080/15287398909531243

Camacho, 2001, Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD)-induced immunotoxicity in peripheral T cells, Toxicology, 165, 51, 10.1016/S0300-483X(01)00391-2

Chen, 2000, Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism, J. Pharmacol. Exp. Ther., 293, 807

Condie, 1996, Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (il-2) expression in the murine t-cell line, el4.Il-2, J. Biol. Chem., 271, 13175, 10.1074/jbc.271.22.13175

Croxford, 2005, Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?, J. Neuroimmunol., 166, 3, 10.1016/j.jneuroim.2005.04.023

Derocq, 1995, Cannabinoids enhance human b-cell growth at low nanomolar concentrations, FEBS Lett., 369, 177, 10.1016/0014-5793(95)00746-V

Do, 2004, Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers nf-kappab-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation, J. Immunol., 173, 2373, 10.4049/jimmunol.173.4.2373

El-Gohary, 2004, Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students, Hum. Exp. Toxicol., 23, 149, 10.1191/0960327104ht426oa

George, 2008, Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells, J. Cell Physiol., 214, 714, 10.1002/jcp.21263

Guzman, 2003, Cannabinoids: potential anticancer agents, Nat. Rev. Cancer, 3, 745, 10.1038/nrc1188

Guzman, 2002, Cannabinoids and cell fate, Pharmacol. Ther., 95, 175, 10.1016/S0163-7258(02)00256-5

Hampson, 1998, Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants, Proc. Natl. Acad. Sci. USA, 95, 8268, 10.1073/pnas.95.14.8268

Hegde, 2008, Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory t cells, Mol. Pharmacol., 74, 20, 10.1124/mol.108.047035

Hengartner, 2000, The biochemistry of apoptosis, Nature, 407, 770, 10.1038/35037710

Herrera, 2006, The cb2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway, Exp. Cell Res., 312, 2121, 10.1016/j.yexcr.2006.03.009

Igney, 2002, Death and anti-death: tumour resistance to apoptosis, Nat. Rev. Cancer, 2, 277, 10.1038/nrc776

Inui, 2002, Cancer anorexia-cachexia syndrome: current issues in research and management, CA Cancer J. Clin., 52, 72, 10.3322/canjclin.52.2.72

Jia, 2006, Delta9-tetrahydrocannabinol-induced apoptosis in jurkat leukemia t cells is regulated by translocation of bad to mitochondria, Mol. Cancer Res., 4, 549, 10.1158/1541-7786.MCR-05-0193

Kamath, 1997, Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo (1997), Toxicol. Appl. Pharmacol., 142, 367, 10.1006/taap.1996.8049

Karst, 2003, Analgesic effect of the synthetic cannabinoid ct-3 on chronic neuropathic pain: a randomized controlled trial, J. Am. Med. Assoc., 290, 1757, 10.1001/jama.290.13.1757

Klein, 1998, Cannabinoid receptors and immunity, Immunol. Today, 19, 373, 10.1016/S0167-5699(98)01300-0

Klein, 2000, The cannabinoid system and cytokine network, Proc. Soc. Exp. Biol. Med., 225, 1, 10.1046/j.1525-1373.2000.22501.x

Klein, 2006, Cannabinoid-induced immune suppression and modulation of antigen-presenting cells, J. Neuroimmune Pharmacol., 1, 50, 10.1007/s11481-005-9007-x

Klein, 1995, Delta 9-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila, Proc. Soc. Exp. Biol. Med., 209, 205, 10.3181/00379727-209-43897b

Kroemer, 2000, Mitochondrial control of cell death, Nat. Med., 6, 513, 10.1038/74994

Lee, 2008, A comparative study on cannabidiol-induced apoptosis in murine thymocytes and el-4 thymoma cells, Int. Immunopharmacol., 8, 732, 10.1016/j.intimp.2008.01.018

Lee, 2001, Differential expression of cannabinoid cb(2) receptor mrna in mouse immune cell subpopulations and following b cell stimulation, Eur. J. Pharmacol., 423, 235, 10.1016/S0014-2999(01)01122-0

Lombard, 2007, Cb2 cannabinoid receptor agonist, jwh-015, triggers apoptosis in immune cells: Potential role for cb2-selective ligands as immunosuppressive agents, Clin. Immunol., 122, 259, 10.1016/j.clim.2006.11.002

Lombard, 2005, Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in delta9-tetrahydrocannabinol (thc)-induced apoptosis of jurkat cells, Leuk. Res., 29, 915, 10.1016/j.leukres.2005.01.014

Lopez-Cepero, 1986, Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro, J. Leukoc. Biol., 39, 679, 10.1002/jlb.39.6.679

Lu, 2006, Cannabinoid treatment suppresses the t-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection, J. Pharmacol. Exp. Ther., 319, 269, 10.1124/jpet.106.108381

Maccarrone, 2000, Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors, J. Biol. Chem., 275, 31938, 10.1074/jbc.M005722200

Mackie, 2006, Cannabinoid receptors as therapeutic targets, Annu. Rev. Pharmacol. Toxicol., 46, 101, 10.1146/annurev.pharmtox.46.120604.141254

McCoy, 1995, Delta 9-tetrahydrocannabinol modulates antigen processing by macrophages, J. Pharmacol. Exp. Ther., 273, 1216

McKallip, 2006, Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and nox4 expression, Mol. Pharmacol., 70, 897, 10.1124/mol.106.023937

McKallip, 2002, Targeting cb2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease, Blood, 100, 627, 10.1182/blood-2002-01-0098

McKallip, 2002, Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo, J. Pharmacol. Exp. Ther., 302, 451, 10.1124/jpet.102.033506

McKallip, 2005, Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response, J. Immunol., 174, 3281, 10.4049/jimmunol.174.6.3281

Pollmann, 2008, Current management associated with multiple sclerosis, CNS Drugs, 22, 291, 10.2165/00023210-200822040-00003

Rachelefsky, 1976, Intact humoral and cell-mediated immunity in chronic marijuana smoking, J. Allergy Clin. Immunol., 58, 483, 10.1016/0091-6749(76)90192-5

Rajesh, 2007, J. Leukoc. Biol., 82, 1382, 10.1189/jlb.0307180

Schwarz, 1994, Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis, J. Neuroimmunol., 55, 107, 10.1016/0165-5728(94)90152-X

Singh, 2008, Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells, Mol. Pharmacol., 73, 1722, 10.1124/mol.107.043406

Tashkin, 2002, Respiratory and immunologic consequences of marijuana smoking, J. Clin. Pharmacol., 42, 71S, 10.1002/j.1552-4604.2002.tb06006.x

Tramer, 2001, Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review, Br. Med. J., 323, 16, 10.1136/bmj.323.7303.16

Varga, 1998, Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension, Faseb J., 12, 1035, 10.1096/fasebj.12.11.1035

Wang, 2001, Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin b-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock, Anal. Biochem., 294, 73, 10.1006/abio.2001.5015

Yebra, 1992, Delta 9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes, Life Sci., 51, 151, 10.1016/0024-3205(92)90009-E

Zhu, 1998, Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of bcl-2 and caspase-1, J. Pharmacol. Exp. Ther., 286, 1103

Zhu, 1995, Delta 9-tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits, J Pharmacol. Exp. Ther., 274, 1001

Zhu, 1994, Delta 9-tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages, J. Pharmacol. Exp. Ther., 270, 1334

Zurier, 1998, Dimethylheptyl-thc-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure, Arthritis Rheum., 41, 163, 10.1002/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9